Synthetic cannabinoids contaminated with rat poison caused blood clotting disorder diagnosed via factor levels
A young adult using synthetic cannabinoids developed severe blood clotting dysfunction from coumarin contamination, with factor level testing enabling rapid diagnosis before confirmatory toxicology results.
Quick Facts
What This Study Found
A young adult presented with elevated INR without known medical history. Factor levels revealed deficiencies in factors II, VII, IX, and X, pointing to superwarfarin-type anticoagulant contamination. The patient later confirmed synthetic cannabinoid use, and bromadiolone testing was positive.
Key Numbers
One patient with acute INR elevation. Deficiencies in factors II, VII, IX, and X identified. Bromadiolone assay positive (confirmed after discharge). Patient initially denied substance use but later confirmed synthetic cannabinoid consumption.
How They Did This
Single case report documenting clinical presentation, diagnostic workup using coagulation factor levels, treatment, and confirmatory toxicology testing.
Why This Research Matters
Coumarin-contaminated synthetic cannabinoids have caused outbreaks of life-threatening coagulopathy. This case demonstrates that factor level testing can enable rapid diagnosis when patients may not initially disclose substance use.
The Bigger Picture
Synthetic cannabinoids contaminated with superwarfarins have caused mass casualty events in several US cities. Having a rapid diagnostic approach helps clinicians identify and treat this life-threatening condition.
What This Study Doesn't Tell Us
Single case report. Factor level patterns can have other causes. Confirmatory assays for toxic coumarin derivatives remain not readily available in most hospitals.
Questions This Raises
- ?How common is coumarin contamination in current synthetic cannabinoid supply?
- ?Should factor level testing be standard for unexplained coagulopathy in young adults?
- ?Would point-of-care superwarfarin testing improve outcomes?
Trust & Context
- Key Stat:
- Factor levels enabled diagnosis before confirmatory assay results
- Evidence Grade:
- Preliminary: single case report with novel diagnostic approach.
- Study Age:
- Published in 2022.
- Original Title:
- Factor-guided diagnosis of coagulopathy associated with coumarin-contaminated synthetic cannabinoids.
- Published In:
- The American journal of emergency medicine, 58, 350.e5-350.e6 (2022)
- Authors:
- Torian, Sterling C, Hayes, Lisa(2), Negrete, Ana
- Database ID:
- RTHC-04269
Evidence Hierarchy
Describes what happened to one person or a small group.
What do these levels mean? →Frequently Asked Questions
What is coumarin contamination?
Some synthetic cannabinoid products are contaminated with superwarfarins (long-acting rat poisons that prevent blood from clotting). These cause persistent and potentially life-threatening bleeding disorders.
How was the diagnosis made?
Blood coagulation factor levels showed deficiencies in factors II, VII, IX, and X, a pattern characteristic of superwarfarin exposure. The patient initially denied drug use but later confirmed synthetic cannabinoid consumption.
Is this common?
Outbreaks of coumarin-contaminated synthetic cannabinoids have been reported in several US cities, causing hundreds of cases of coagulopathy and some deaths.
Read More on RethinkTHC
- 420-sober-survival-guide
- CBT-cannabis-recovery
- THC-purity-potency-label-meaning
- cannabis-relapse-cycle-pattern
- cold-turkey-vs-taper-quit-weed
- dab-concentrate-addiction-withdrawal
- dating-sober-after-quitting-weed
- delta-8-addiction-withdrawal
- edible-addiction-withdrawal-different
- edibles-psychosis-emergency-room
- exercise-quitting-weed-anxiety-brain
- grieving-quitting-weed-loss
- healthiest-way-to-consume-cannabis
- help-someone-quit-weed
- how-cannabis-products-made-concentrates-edibles
- how-to-quit-weed
- journaling-weed-withdrawal
- laced-weed-fentanyl-contaminated-vape
- legal-weed-vs-street-weed-quality-safety
- marijuana-anonymous-SMART-recovery-compare
- meditation-mindfulness-weed-withdrawal
- partner-still-smokes-weed
- partner-still-smokes-weed-quitting
- pink-cloud-sobriety-cannabis
- quit-weed-cold-turkey
- quit-weed-or-cut-back-which-is-better
- quit-weed-regret-went-back
- quitting-dabs-withdrawal
- quitting-edibles-withdrawal
- quitting-weed-20s
- quitting-weed-30s
- quitting-weed-after-years
- quitting-weed-during-crisis-divorce-job-loss
- quitting-weed-exercise
- quitting-weed-grief-loss-coping
- quitting-weed-legal-state
- quitting-weed-success-stories
- quitting-weed-triggers-environment
- relapsed-smoking-weed-what-to-do
- relapsed-weed
- sativa-vs-indica-difference-myth
- should-i-quit-weed
- sober-music-festival-concert-without-weed
- supplements-weed-withdrawal
- telling-friends-quitting-weed
- weed-potency-withdrawal
- weed-relapse-prevention-plan
- weed-relapse-why-it-happens
- weed-ritual-replacement
- weed-ruined-relationships
- weed-social-media-triggers-quit
Cite This Study
https://rethinkthc.com/research/RTHC-04269APA
Torian, Sterling C; Hayes, Lisa; Negrete, Ana. (2022). Factor-guided diagnosis of coagulopathy associated with coumarin-contaminated synthetic cannabinoids.. The American journal of emergency medicine, 58, 350.e5-350.e6. https://doi.org/10.1016/j.ajem.2022.05.005
MLA
Torian, Sterling C, et al. "Factor-guided diagnosis of coagulopathy associated with coumarin-contaminated synthetic cannabinoids.." The American journal of emergency medicine, 2022. https://doi.org/10.1016/j.ajem.2022.05.005
RethinkTHC
RethinkTHC Research Database. "Factor-guided diagnosis of coagulopathy associated with coum..." RTHC-04269. Retrieved from https://rethinkthc.com/research/torian-2022-factorguided-diagnosis-of-coagulopathy
Access the Original Study
Study data sourced from PubMed, a service of the U.S. National Library of Medicine, National Institutes of Health.
This study breakdown was produced by the RethinkTHC research team. We analyze and report published research findings without making health recommendations. All interpretations are based solely on the published abstract and study data.